Fidelta: <b>Fidelta</b> Announces An Extension Of Its Drug Discovery Service Agreement With Heptares

Zagreb, Croatia, 5th September 2017 Fidelta, a Galapagos company, is pleased to announce the continuation of an agreement with Heptares, whereby Fidelta will provide medicinal chemistry, DMPK and pharmacology services to advance Heptares drug discovery programs against emerging GPCR targets.Adrijana Vinter, Managing Director, Fidelta commented, We are excited to continue working together...